Nitrazepam in the treatmet of epilepsy in childhood
Insights
Nitrazepam effectively treats minor motor seizures in children, especially infantile spasms, offering significant relief. While beneficial for myoclonic seizures, its efficacy may be limited in older children.
Area of Science:
- Pediatric Neurology
- Clinical Pharmacology
Background:
- Epilepsy is a common neurological disorder in children, presenting diverse seizure types.
- Minor motor seizures, including infantile spasms, pose significant treatment challenges.
Purpose of the Study:
- To evaluate the anticonvulsant efficacy and safety of nitrazepam in pediatric patients.
- To compare nitrazepam's effectiveness across different seizure patterns.
Main Methods:
- A study involving 31 children with various seizure types.
- Dosage of nitrazepam ranged from 0.3 to 2.2 mg/kg daily.
- Clinical observation of seizure reduction and side effects.
Main Results:
- Significant improvement or complete relief in 11 of 15 children with minor motor seizures.
- Variable response in 9 of 16 children with miscellaneous seizures.
- Drowsiness and ataxia were common mild side effects; three cases of aspiration pneumonia noted.
Conclusions:
- Nitrazepam is a safe and effective treatment for minor motor seizures, particularly infantile spasms, potentially superior to ACTH.
- Its utility for myoclonic seizures in older children is noted but appears more limited in duration and degree.
Abstract:
The anticonvulsant activity of nitrazepam (Mogadon) was studied in 31 children with various seizure patterns. Dosage ranged from 0.3 to 2.2 mg. per kg. body weight daily.Eleven of 15 children with minor motor seizures showed improvement and six obtained complete relief. Nine of 16 with miscellaneous seizures were improved, but only one was completely relieved and the other eight responded to a variable extent. In cases with more than one type of seizure, the myoclonic elements were those most often diminished, but sometimes this effect was only temporary. Side effects were transient and usually mild, consisting of drowsiness, ataxia, slurred speech and excessive secretion of mucus and saliva. However, three cases of aspiration pneumonia were encountered and may have been at least partly due to the side effects. No hematological or biochemical abnormalities were observed.The results indicate that nitrazepam is a relatively safe and effective drug in the treatment of minor motor seizures, particularly infantile spasms, and is even more useful than ACTH in this serious form of epilepsy. In older children its value is chiefly for myoclonic seizures, but the degree and duration of its effectiveness appear to be more limited.
Related Concept Videos
01:08Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:14Antiepileptic Drugs: Glutamate Antagonists
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...